Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)RANOLAZINE STUDY: Speckle Tracking Derived Myocardial Strain
Withdrawn
- Conditions
- Ischaemic Myocardial DysfunctionSevere Coronary Artery Disease
- Interventions
- First Posted Date
- 2017-08-22
- Last Posted Date
- 2018-04-10
- Lead Sponsor
- Saint Thomas Health
- Registration Number
- NCT03257683
- Locations
- 🇺🇸
Saint Thomas Heart at Saint Thomas West, Nashville, Tennessee, United States
CABG REVEAL: Atrial Fibrillation After Coronary Artery Bypass Graft
Completed
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2014-06-23
- Last Posted Date
- 2020-11-06
- Lead Sponsor
- Saint Thomas Health
- Target Recruit Count
- 51
- Registration Number
- NCT02169622
- Locations
- 🇺🇸
Saint Thomas West Hospital, Nashville, Tennessee, United States
Neuropathic Investigation and Anticholinergic Treatment of Bladder Dysfunction in Diabetes and Stroke Patients
Early Phase 1
Withdrawn
- Conditions
- Urinary IncontinenceBladder Dysfunction
- First Posted Date
- 2008-07-14
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- Saint Thomas Health
- Registration Number
- NCT00713921
- Locations
- 🇺🇸
Vanderbilt Univiersity, Nashville, Tennessee, United States
News
No news found